Amryt Pharma plc American Depositary Shares
AMYT
AMYT was delisted on the 11th of April, 2023.
0 hedge funds and large institutions have $0 invested in Amryt Pharma plc American Depositary Shares in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 79 closing their positions.
100% less funds holding
Funds holding: 79 → 0 (-79)
100% less funds holding in top 10
Funds holding in top 10: 11 → 0 (-11)
100% less capital invested
Capital invested by funds: $720M → $0 (-$720M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 79
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Athyrium Capital Management
New York
|
-$129M |
| 2 |
HCM
Highbridge Capital Management
New York
|
-$92.3M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$91.5M |
| 4 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$38.9M |
| 5 |
Morgan Stanley
New York
|
-$36.5M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$146 | -10 | Closed |
|
|
FDCDDQ
77
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$58 | -4 | Closed |
|
|
LWANC
78
Laurel Wealth Advisors (North Carolina)
Charlotte,
North Carolina
| – | -$59 | -4 | Closed |
|
|
AIG
79
American International Group
New York
| – | -$29 | -2 | Closed |
|
AMYT Hedge Fund Activity: Q2 2023 in Review
0 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q2 2023, worth a combined $0 — down 100% from $720M a quarter earlier.
Sellers outnumbered buyers: 79 funds closed out of AMYT and 0 opened new positions — a net loss of 79 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Athyrium Capital Management, exiting entirely with an estimated $129M sold.
- 0 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q2 2023, down from 79 in Q1 2023.
- Funds reported $0 of Amryt Pharma plc American Depositary Shares stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new Amryt Pharma plc American Depositary Shares positions in Q2 2023 and 79 closed out, a net change of -79 holders.
- The largest Amryt Pharma plc American Depositary Shares seller in Q2 2023 was Athyrium Capital Management, an estimated $129M sold.
Based on aggregated 13F filings for Q2 2023.